Evidence map›Paper›PMID 32772419›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2020

Noncanonical function of long myosin light chain kinase in increasing ER-PM junctions and augmentation of SOCE.

Nityanand Srivastava, Mohammad Tauseef, Ruhul Amin, Bhagwati Joshi, Jagdish Chandra Joshi, Vidisha Kini, Jennifer Klomp, Weenan Li, Nebojsa Knezevic, Nicolas Barbera and 6 more

Open access · hybridAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Noncanonical function of long myosin light chain kinase in increasing ER-PM junctions and augmentation of SOCE.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Nityanand SrivastavaDepartment of Pharmacology and Center for Lung and Vascular Biology, The University of Illinois, College of Medicine, Chicago, IL, USA.
Mohammad TauseefDepartment of Pharmacology and Center for Lung and Vascular Biology, The University of Illinois, College of Medicine, Chicago, IL, USA.
Ruhul AminDepartment of Pharmacology and Center for Lung and Vascular Biology, The University of Illinois, College of Medicine, Chicago, IL, USA.
Bhagwati JoshiDepartment of Pharmacology and Center for Lung and Vascular Biology, The University of Illinois, College of Medicine, Chicago, IL, USA.
Jagdish Chandra JoshiDepartment of Pharmacology and Center for Lung and Vascular Biology, The University of Illinois, College of Medicine, Chicago, IL, USA.
Vidisha KiniDepartment of Pharmacology and Center for Lung and Vascular Biology, The University of Illinois, College of Medicine, Chicago, IL, USA.
Jennifer KlompDepartment of Pharmacology and Center for Lung and Vascular Biology, The University of Illinois, College of Medicine, Chicago, IL, USA.
Weenan LiDepartment of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN, USA.
Nebojsa KnezevicDepartment of Pharmacology and Center for Lung and Vascular Biology, The University of Illinois, College of Medicine, Chicago, IL, USA.
Nicolas BarberaDepartment of Medicine, The Uniiversity of Illinois, Chicago, IL, USA.
Shahid SiddiquiDepartment of Pharmacology and Center for Lung and Vascular Biology, The University of Illinois, College of Medicine, Chicago, IL, USA.
Alexander ObukhovDepartment of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN, USA.
Andrei KarginovDepartment of Pharmacology and Center for Lung and Vascular Biology, The University of Illinois, College of Medicine, Chicago, IL, USA.
Irena LevitanDepartment of Medicine, The Uniiversity of Illinois, Chicago, IL, USA.
Yulia KomarovaDepartment of Pharmacology and Center for Lung and Vascular Biology, The University of Illinois, College of Medicine, Chicago, IL, USA.
Dolly MehtaDepartment of Pharmacology and Center for Lung and Vascular Biology, The University of Illinois, College of Medicine, Chicago, IL, USA.
University of Illinois Chicago · USIllinois College · USUniversity of Illinois Urbana-Champaign · USChicago State University · USIndiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

TRPC6 Regulation of Lung Endothelial Barrier FunctionP01HL060678 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MALIK, ASRAR B. · 2000 to 2020
$40.1M
Trpm2 Regulation of Phagocyte Bactericidal Activity and Resolution of Lung InjuryP01HL077806 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ZHAO, YOU-YANG · 2005 to 2019
$27.0M
TRAINING PROGRAM IN LUNG BIOLOGY AND PATHOBIOLOGYT32HL007829 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DOLLY MEHTA · 1995 to 2026
$15.6M
Cholesterol Regulation of Endothelial K+ ChannelsR01HL073965 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI LEVITAN, IRENA · 2004 to 2024
$7.3M
Impact of dyslipidemia on endothelial biomechanicsR01HL083298 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LEVITAN, IRENA, MINSHALL, RICHARD D · 2007 to 2021
$7.0M
Focal Adhesion Kinase Regulation of Lung Vascular Permeability and EdemagenesisR01HL084153 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MEHTA, DOLLY · 2007 to 2022
$5.4M
NHLBI NIH HHS P01 HL060678NHLBI NIH HHS P01 HL077806NHLBI NIH HHS R01 HL073965NHLBI NIH HHS R01 HL083298NHLBI NIH HHS R01 HL084153NHLBI NIH HHS T32 HL007829NIH| National Heart, Lung, and Blood Institute (NHLBI) HL137179-01
6 · The paper itself

Abstract

Increased endothelial permeability leads to excessive exudation of plasma proteins and leukocytes in the interstitium, which characterizes several vascular diseases including acute lung injury. The myosin light chain kinase long (MYLK-L) isoform is canonically known to regulate the endothelial permeability by phosphorylating myosin light chain (MLC-P). Compared to the short MYLK isoform, MYLK-L contains an additional stretch of ~919 amino acid at the N-terminus of unknown function. We show that thapsigargin and thrombin-induced SOCE was markedly reduced in Mylk-L

Indexed as

Capillary PermeabilityAcute Lung InjuryAnimalsCalcium-Binding ProteinsCell MembraneEndoplasmic ReticulumHumansHuman Umbilical Vein Endothelial CellsIsoenzymesLungMiceMice, Inbred C57BLMice, KnockoutMyosin-Light-Chain KinaseNeoplasm ProteinsStromal Interaction Molecule 1Calcium-Binding ProteinsIsoenzymesMYLK protein, humanMyosin-Light-Chain KinaseNeoplasm ProteinsSTIM1 protein, humanStromal Interaction Molecule 1endoplasmic reticulum-plasma membrane junctionslong myosin light chain kinasestore-operated calcium entrystromal interacting molecule 1vascular permeability

Identifiers

PMID32772419
PMCPMC7496663
OpenAlexW3047628861

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.